Alerts will be sent to your verified email
Verify Email
KABRADG
|
Kabra Drugs
|
Lasa Supergenerics
|
Shanmuga Hospital
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
21.53 % | -8.32 % | 55.38 % |
|
5yr average Equity Multiplier
|
-0.87 | 1.44 | 1.81 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 0.77 | 2.16 |
|
5yr Avg Net Profit Margin
|
0.0 | -8.22 % | 14.34 % |
|
Price to Book
|
2.19 | 0.62 | 1.44 |
|
P/E
|
0.0 | 0.0 | 13.61 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 11.27 Days | 3.14 Days |
|
Inventory Days
|
0.0 | 46.83 Days | 13.93 Days |
|
Days Receivable
|
0.0 | 10.61 Days | 59.96 Days |
|
Days Payable
|
0.0 | 83.41 Days | 51.52 Days |
|
5yr Average Interest Coverage Ratio
|
-1068.45 | -18.91 | 80.15 |
|
5yr Avg ROCE
|
21.53 % | 1.03 % | 68.42 % |
|
5yr Avg Operating Profit Margin
|
0.0 | 9.99 % | 20.12 % |
|
5 yr average Debt to Equity
|
-1.45 | 0.2 | 0.39 |
|
5yr CAGR Net Profit
|
43.36 % | n/a | -8.93 % |
|
5yr Average Return on Assets
|
-21.34 % | -5.59 % | 33.09 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 53.65 % | 72.06 % |
|
Share Pledged by Promoters
|
0.0 | 20.66 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 9.87 % | 0.11 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Kabra Drugs
|
Lasa Supergenerics
|
Shanmuga Hospital
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|